Literature DB >> 18804406

Expression of osteopontin and its receptors in ameloblastomas.

Yi-Ping Wang1, Bu-Yuan Liu.   

Abstract

This study used an immunohistochemical method to examine the expression of osteopontin (OPN) in 30 ameloblastomas and of integrin alpha(v) and CD44v6 in 20 of these 30 ameloblastomas. We found that the positive staining rate in ameloblastomas was 87% for OPN, 45% for integrin alpha(v), and 90% for CD44v6. Both ameloblast-like and stellate reticulum-like cells showed a high expression of OPN and CD44v6. There was also a strong integrin alpha(v) immunostaining on the cell membrane of osteoclasts. Binding of OPN to osteoclast cell membrane receptor integrin alpha(v) can activate the osteoclast and increase its osteolytic activity. In addition, binding of OPN to ameloblastoma tumor cell membrane receptor CD44v6 can enhance tumor cell migration, invasion and spread. Therefore, we suggest that the local aggressive behavior and high osteolytic ability of ameloblastomas in the jawbones can be explained by the high expression of OPN and CD44v6 in ameloblastoma cells and the high expression of integrin alpha(v) in osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804406     DOI: 10.1016/j.oraloncology.2008.07.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.

Authors:  Gang Wu; Jing-Jing Guo; Zhen-Yu Ma; Jie Wang; Zhong-Wen Zhou; Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions.

Authors:  Eduardo Alonso Cruz Monroy; Pedro Paulo de Andrade Santos; Maria Luiza Diniz de Sousa Lopes; Adalberto Mosqueda-Taylor; Leão Pereira Pinto; Lélia Batista de Souza
Journal:  Histochem Cell Biol       Date:  2018-07-03       Impact factor: 4.304

3.  CD10 and osteopontin expression in dentigerous cyst and ameloblastoma.

Authors:  Shaimaa M Masloub; Adel M Abdel-Azim; Ehab S Abd Elhamid
Journal:  Diagn Pathol       Date:  2011-05-24       Impact factor: 2.644

Review 4.  Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update.

Authors:  Ravleen Nagi; Shashikant Sahu; N Rakesh
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

Review 5.  Proteoglycans as potential biomarkers in odontogenic tumors.

Authors:  Zaira Gómez-Herrera; Nelly Molina-Frechero; Pablo Damián-Matsumura; Ronell Bologna-Molina
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

6.  Molecular markers of tumor invasiveness in ameloblastoma: An update.

Authors:  Yi Zhong; Wei Guo; Li Wang; Xinming Chen
Journal:  Ann Maxillofac Surg       Date:  2011-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.